M J Camarasa - JoVE Visualize

Showing results (1-10 of 53) with videos related to

Pageof 6

Sort By:

Antiviral Research|November 1, 1996

Novel L-lyxo and 5'-deoxy-5'-modified TSAO-T analogs: synthesis and anti-HIV-1 activityS Ingate, E De Clercq, J Balzarini, et al.

Biochemical and Biophysical Research Communications|June 26, 1995

Sensitivity/resistance profile of a simian immunodeficiency virus containing the reverse transcriptase gene of human immunodeficiency virus type 1 (HIV-1) toward the HIV-1-specific non-nucleoside reverse transcriptase inhibitorsJ Balzarini, M Weeger, M J Camarasa, et al.

Bioorganic & Medicinal Chemistry|October 1, 1993

Glycosyl-oxycarbonylaminosulfonyl-2',3'-dideoxynucleoside derivatives as lipophilic nucleotide mimics. Synthesis and anti-HIV activityM J Pérez-Pérez, J Balzarini, E De Clercq, et al.

Antiviral Chemistry & Chemotherapy|February 29, 2000

TSAO-T analogues bearing amino acids at position N-3 of thymine: synthesis and anti-human immunodeficiency virus activityC Chamorro, E De Clercq, J Balzarini, et al.

Virology|October 1, 1993

Knocking-out concentrations of HIV-1-specific inhibitors completely suppress HIV-1 infection and prevent the emergence of drug-resistant virusJ Balzarini, A Karlsson, M J Pérez-Pérez, et al.

Biochemistry|February 24, 2000

Human immunodeficiency virus type 1 reverse transcriptase dimer destabilization by 1-[Spiro[4"-amino-2",2" -dioxo-1",2" -oxathiole-5",3'-[2', 5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]]]-3-ethylthy mineN Sluis-Cremer, G I Dmitrienko, J Balzarini, et al.

Antiviral Research|June 1, 1995

Synthesis and anti-HIV-1 activity of novel TSAO-T derivatives modified at the 2'- and 5'-positions of the sugar moietyS Ingate, M J Pérez-Pérez, E De Clercq, et al.

Biochemical and Biophysical Research Communications|June 30, 1994

Sensitivity of (138 Glu-->Lys) mutated human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) to HIV-1-specific RT inhibitorsJ Balzarini, J P Kleim, G Riess, et al.

Nucleosides, Nucleotides & Nucleic Acids|September 21, 2001

4"-H-TSAO-T, a novel prototype in the HIV-1 specific TSAO familyE Lobatón, S Velázquez, A San-Félix, et al.

Journal of Medicinal Chemistry|August 7, 1992

TSAO analogues. Stereospecific synthesis and anti-HIV-1 activity of 1-[2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]-3'-spiro -5''- (4''-amino-1'',2''-oxathiole 2'',2''-dioxide) pyrimidine and pyrimidine-modified nucleosidesM J Pérez-Pérez, A San-Félix, J Balzarini, et al.

Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:

Pageof 6

Antiviral Research|November 1, 1996

Novel L-lyxo and 5'-deoxy-5'-modified TSAO-T analogs: synthesis and anti-HIV-1 activityS Ingate, E De Clercq, J Balzarini, et al.

Biochemical and Biophysical Research Communications|June 26, 1995

Sensitivity/resistance profile of a simian immunodeficiency virus containing the reverse transcriptase gene of human immunodeficiency virus type 1 (HIV-1) toward the HIV-1-specific non-nucleoside reverse transcriptase inhibitorsJ Balzarini, M Weeger, M J Camarasa, et al.

Bioorganic & Medicinal Chemistry|October 1, 1993

Glycosyl-oxycarbonylaminosulfonyl-2',3'-dideoxynucleoside derivatives as lipophilic nucleotide mimics. Synthesis and anti-HIV activityM J Pérez-Pérez, J Balzarini, E De Clercq, et al.

Antiviral Chemistry & Chemotherapy|February 29, 2000

TSAO-T analogues bearing amino acids at position N-3 of thymine: synthesis and anti-human immunodeficiency virus activityC Chamorro, E De Clercq, J Balzarini, et al.

Virology|October 1, 1993

Knocking-out concentrations of HIV-1-specific inhibitors completely suppress HIV-1 infection and prevent the emergence of drug-resistant virusJ Balzarini, A Karlsson, M J Pérez-Pérez, et al.

Biochemistry|February 24, 2000

Human immunodeficiency virus type 1 reverse transcriptase dimer destabilization by 1-[Spiro[4"-amino-2",2" -dioxo-1",2" -oxathiole-5",3'-[2', 5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]]]-3-ethylthy mineN Sluis-Cremer, G I Dmitrienko, J Balzarini, et al.

Antiviral Research|June 1, 1995

Synthesis and anti-HIV-1 activity of novel TSAO-T derivatives modified at the 2'- and 5'-positions of the sugar moietyS Ingate, M J Pérez-Pérez, E De Clercq, et al.

Biochemical and Biophysical Research Communications|June 30, 1994

Sensitivity of (138 Glu-->Lys) mutated human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) to HIV-1-specific RT inhibitorsJ Balzarini, J P Kleim, G Riess, et al.

Nucleosides, Nucleotides & Nucleic Acids|September 21, 2001

4"-H-TSAO-T, a novel prototype in the HIV-1 specific TSAO familyE Lobatón, S Velázquez, A San-Félix, et al.

Journal of Medicinal Chemistry|August 7, 1992

TSAO analogues. Stereospecific synthesis and anti-HIV-1 activity of 1-[2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]-3'-spiro -5''- (4''-amino-1'',2''-oxathiole 2'',2''-dioxide) pyrimidine and pyrimidine-modified nucleosidesM J Pérez-Pérez, A San-Félix, J Balzarini, et al.

Pageof 6